Acasunlimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Acasunlimab, covering 2026-04-08 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) [Phase 3]